Spots Global Cancer Trial Database for stem cell
Every month we try and update this database with for stem cell cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Cyclophosphamide for Hematopoietic Stem Cell Mobilization in Patients With a Hematologic Malignancy | NCT02139280 | Hematologic Mal... | Cyclophosphamid... | 18 Years - | Dartmouth-Hitchcock Medical Center | |
| Randomized Study Comparing the Effect of Dasatinib and Imatinib on Malignant Stem Cells in Chronic Myeloid Leukemia | NCT00852566 | Chronic Myeloid... | Imatinib Dasatinib | 18 Years - | Norwegian University of Science and Technology | |
| Cyclophosphamide for Hematopoietic Stem Cell Mobilization in Patients With a Hematologic Malignancy | NCT02139280 | Hematologic Mal... | Cyclophosphamid... | 18 Years - | Dartmouth-Hitchcock Medical Center | |
| Study of Stem Cell Transplant vs. Non-Transplant Therapies in High-Risk Myelofibrosis | NCT04217356 | Myelofibrosis High-Risk Cance... Bone Marrow Can... | Hematopoietic s... Ruxolitinib Hydroxyurea | 18 Years - 70 Years | University Health Network, Toronto | |
| Safety and Efficacy of Mesenchymal Stem Cell for Radiation-induced Hyposalivation and Xerostomia in Previous Head and Neck Cancer Patients | NCT04776538 | Xerostomia Foll... | Stem cells Placebo | 18 Years - 70 Years | Rigshospitalet, Denmark | |
| Ph2 NK Cell Enriched DCIs w/wo RLR9 Agonist, DUK-CPG-001 From Donors Following Allogeneic SCT | NCT02452697 | Myeloid Maligna... Lymphoid Malign... | NK Cell enriche... NK-DLI + DUK-CP... | 18 Years - | Duke University | |
| Pilot Study of Bone Marrow/Stem Cells in Grade IV Malignant Glioma | NCT01639612 | Grade IV Malign... | ALD-451 | 18 Years - | Duke University | |
| Intravenous Administration of RGI-2001 in Patient Undergoing Allogenic Hematopoietic Stem Cell Transplantation (AHSCT) | NCT01379209 | Graft Versus Ho... | RGI-2001 Calcineurin Inh... Allogeneic Hema... Conditioning Re... Allogeneic Bone... Methotrexate Mofetil Mycophe... sirolimus | 18 Years - | Regimmune Corporation | |
| Biological Sample Collection for Research and Biobanking | NCT04270604 | Parkinson Disea... Diabetes Mellit... Macular Degener... ALS Cancer Alzheimer Disea... Huntington Dise... | Biological samp... | 1 Month - 100 Years | New York Stem Cell Foundation Research Institute | |
| Parotid-gland Stem-cell Sparing Intensity-modulated Radiotherapy | NCT01955239 | Head and Neck C... | Intensity-modul... | 18 Years - | University Medical Center Groningen | |
| Stem Cell Harvesting Using GCSF Plus Plerxiafor, in First -Line, for Heavily Pre- Treated Pediatric Oncology Patients. | NCT02006225 | Autologous Stem... | Plerixafor | - 30 Years | Tel-Aviv Sourasky Medical Center | |
| Safety and Efficacy of Mesenchymal Stem Cell for Radiation-induced Hyposalivation and Xerostomia in Previous Head and Neck Cancer Patients | NCT04776538 | Xerostomia Foll... | Stem cells Placebo | 18 Years - 70 Years | Rigshospitalet, Denmark | |
| Thiotepa-Clofarabine-Busulfan With Allogeneic Stem Cell Transplant for High Risk Malignancies | NCT00857389 | Stem Cell Trans... Leukemia Lymphoma | Thiotepa Clofarabine Busulfan Allogeneic Stem... Thymoglobulin (... G-CSF (Filgrast... Tacrolimus Methotrexate Cyclophosphamid... Mesna | - 60 Years | M.D. Anderson Cancer Center | |
| Side Population in Pancreatic Ductal Adenocarcinoma (PDAC) | NCT00936104 | Neoplasm Pancreas | 18 Years - 85 Years | University Hospital, Gasthuisberg | ||
| Safety Study of Parathyroid Hormone in Patients Needing Additional Stem Cell Mobilization. | NCT00299780 | Lymphoma Multiple Myelom... Acute Myelogeno... | Stem cell mobil... | 18 Years - 75 Years | Massachusetts General Hospital | |
| Biological Sample Collection for Research and Biobanking | NCT04270604 | Parkinson Disea... Diabetes Mellit... Macular Degener... ALS Cancer Alzheimer Disea... Huntington Dise... | Biological samp... | 1 Month - 100 Years | New York Stem Cell Foundation Research Institute | |
| Biological Sample Collection for Research and Biobanking | NCT04270604 | Parkinson Disea... Diabetes Mellit... Macular Degener... ALS Cancer Alzheimer Disea... Huntington Dise... | Biological samp... | 1 Month - 100 Years | New York Stem Cell Foundation Research Institute | |
| The Collection of Peripheral Blood Lymphocytes and Marrow Progenitor Cells From Normal Volunteers and Volunteers With Lymphoid or Hematologic Malignancies | NCT00001432 | Chronic Myeloid... Healthy Hematologic Neo... Lymphoma | - | National Institutes of Health Clinical Center (CC) | ||
| Cyclophosphamide for Hematopoietic Stem Cell Mobilization in Patients With a Hematologic Malignancy | NCT02139280 | Hematologic Mal... | Cyclophosphamid... | 18 Years - | Dartmouth-Hitchcock Medical Center | |
| Rituximab, Yttrium Y 90 Ibritumomab Tiuxetan, Melphalan, and Autologous Peripheral Stem Cell Transplant in Treating Patients With Previously Treated Multiple Myeloma | NCT00477815 | Multiple Myelom... | rituximab melphalan Stem Cell Sargramostim (G... 90Y-Zevalin 111In Zevalin | 18 Years - 120 Years | Mayo Clinic | |
| Parotid-gland Stem-cell Sparing Intensity-modulated Radiotherapy | NCT01955239 | Head and Neck C... | Intensity-modul... | 18 Years - | University Medical Center Groningen | |
| Comparing Two Diets in Patients Undergoing HSCT or Remission Induction Chemo for Acute Leukemia and MDS (UF-BMT-LDND-101) | NCT03016130 | Leukemia Myelodysplastic... | Diet | 18 Years - | University of Florida | |
| Side Population in Pancreatic Ductal Adenocarcinoma (PDAC) | NCT00936104 | Neoplasm Pancreas | 18 Years - 85 Years | University Hospital, Gasthuisberg | ||
| Stem Cell Harvesting Using GCSF Plus Plerxiafor, in First -Line, for Heavily Pre- Treated Pediatric Oncology Patients. | NCT02006225 | Autologous Stem... | Plerixafor | - 30 Years | Tel-Aviv Sourasky Medical Center | |
| Side Population in Pancreatic Ductal Adenocarcinoma (PDAC) | NCT00936104 | Neoplasm Pancreas | 18 Years - 85 Years | University Hospital, Gasthuisberg | ||
| Melphalan+Bortezomib as a Conditioning Regimen for Autologous and Allogeneic Stem Cell Transplants in Multiple Myeloma | NCT00948922 | Multiple Myelom... | Bortezomib Melphalan Autologous Stem... Fludarabine Allogeneic Stem... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for PCOS | NCT06143527 | Polycystic Ovar... Polycystic Ovar... PCOS | AlloRx | 18 Years - | The Foundation for Orthopaedics and Regenerative Medicine | |
| A Safety Study Looking at the Combination of Velcade and G-CSF in Patients With Myeloma or Lymphoma | NCT01171092 | Malignant Lymph... Autologous Tran... | bortezomib and ... | 18 Years - | University of Kansas Medical Center | |
| Melphalan+Bortezomib as a Conditioning Regimen for Autologous and Allogeneic Stem Cell Transplants in Multiple Myeloma | NCT00948922 | Multiple Myelom... | Bortezomib Melphalan Autologous Stem... Fludarabine Allogeneic Stem... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Autologous Stem Cell Transplant With Pomalidomide (CC-4047®) Maintenance Versus Continuous Clarithromycin/ Pomalidomide / Dexamethasone Salvage Therapy in Relapsed or Refractory Multiple Myeloma | NCT01745588 | Multiple Myelom... | Pomalidomide stem cell Dexamethasone Clarithromycin | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Melphalan+Bortezomib as a Conditioning Regimen for Autologous and Allogeneic Stem Cell Transplants in Multiple Myeloma | NCT00948922 | Multiple Myelom... | Bortezomib Melphalan Autologous Stem... Fludarabine Allogeneic Stem... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Study of Autologous Fat Enhanced w/ Regenerative Cells Transplanted to Reconstruct Breast Deformities After Lumpectomy | NCT00616135 | Breast Neoplasm... Carcinoma, Duct... Mammaplasty Mastectomy, Seg... | ADRC-Enhanced A... | 18 Years - 75 Years | Cytori Therapeutics | |
| A Safety Study Looking at the Combination of Velcade and G-CSF in Patients With Myeloma or Lymphoma | NCT01171092 | Malignant Lymph... Autologous Tran... | bortezomib and ... | 18 Years - | University of Kansas Medical Center | |
| Exploratory Trial to Estimate Proportion of Patients With Tumor Cell Contaminated Leukapheresis Products With and Without Bortezomib With In-vivo Purging - Multiple Myeloma (MM) | NCT02703779 | Multiple Myelom... | Bortezomib Granulocyte col... Mozobil | 18 Years - | University of Kansas Medical Center | |
| Side Population in Pancreatic Ductal Adenocarcinoma (PDAC) | NCT00936104 | Neoplasm Pancreas | 18 Years - 85 Years | University Hospital, Gasthuisberg | ||
| The Role of Mesenchymal Stem Cell and Exosome in Treating Pilonidal Sinus Disease in Children | NCT06391307 | Pilonidal Sinus Pilonidal Disea... | Crystallized ph... Crystallized ph... Crystallized ph... Crystallized ph... | 1 Day - 18 Years | Necmi Kadıoğlu Hospital | |
| Comparing Two Diets in Patients Undergoing HSCT or Remission Induction Chemo for Acute Leukemia and MDS (UF-BMT-LDND-101) | NCT03016130 | Leukemia Myelodysplastic... | Diet | 18 Years - | University of Florida | |
| Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for PCOS | NCT06143527 | Polycystic Ovar... Polycystic Ovar... PCOS | AlloRx | 18 Years - | The Foundation for Orthopaedics and Regenerative Medicine | |
| Study of KIR-Ligand Mismatched Haplo-Identical Natural Killer Cells Transfused Before Autologous Stem Cell Transplant | NCT00089453 | Multiple Myelom... | Dexamethasone Cyclophosphamid... Melphalan Fludarabine Bortezomide Leukapheresis Interleukin Infusion #1 Leukapheresis #... Infusion #2 Auto Graft | 18 Years - | University of Arkansas | |
| Thiotepa-Clofarabine-Busulfan With Allogeneic Stem Cell Transplant for High Risk Malignancies | NCT00857389 | Stem Cell Trans... Leukemia Lymphoma | Thiotepa Clofarabine Busulfan Allogeneic Stem... Thymoglobulin (... G-CSF (Filgrast... Tacrolimus Methotrexate Cyclophosphamid... Mesna | - 60 Years | M.D. Anderson Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
